{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:28:23Z","timestamp":1779337703220,"version":"3.51.4"},"reference-count":43,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.3892\/ijo.2014.2746","type":"journal-article","created":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T12:52:16Z","timestamp":1415623936000},"page":"741-749","source":"Crossref","is-referenced-by-count":6,"title":["Combination effect of photodynamic therapy using NPe6 with pemetrexed for human malignant pleural mesothelioma cells"],"prefix":"10.3892","volume":"46","author":[{"given":"SACHIO","family":"MAEHARA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JITSUO","family":"USUDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAICHIRO","family":"ISHIZUMI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHUJI","family":"ICHINOSE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEISHI","family":"OHTANI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TATSUYA","family":"INOUE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KENTARO","family":"IMAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIDEYUKI","family":"FURUMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUJIN","family":"KUDO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NAOHIRO","family":"KAJIWARA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TATSUYA","family":"OHIRA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NORIHIKO","family":"IKEDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,11,10]]},"reference":[{"key":"key20180107184050_b1-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/sj.bjc.6690105","article-title":"The European mesothelioma epidemic","volume":"79","author":"Peto","year":"1999","journal-title":"Br J Cancer"},{"key":"key20180107184050_b2-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/oxfordjournals.aje.a009093","article-title":"Analysis of current trends in United States mesothelioma incidence","volume":"145","author":"Price","year":"1997","journal-title":"Am J Epidemiol"},{"key":"key20180107184050_b3-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.bjc.6602307","article-title":"The expected burden of mesothelioma mortality in Great Britan from 2002 to 2050","volume":"92","author":"Hodgson","year":"2005","journal-title":"Br J Cancer"},{"key":"key20180107184050_b4-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/bjc.2011.563","article-title":"Estimating the asbestos-related lung cancer burden from mesothelioma mortality","volume":"106","author":"McCormack","year":"2012","journal-title":"Br J Cancer"},{"key":"key20180107184050_b5-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1378\/chest.123.2.551","article-title":"Surgical treatment of malignant pleural mesothelioma: a review","volume":"123","author":"Van Ruth","year":"2003","journal-title":"Chest"},{"key":"key20180107184050_b6-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the mesothelioma and radical surgery (MARS) randomized feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol"},{"key":"key20180107184050_b7-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF02306613","article-title":"Surgically debulked malignant pleural mesothelioma: results and prognostic factors","volume":"4","author":"Pass","year":"1997","journal-title":"Ann Surg Oncol"},{"key":"key20180107184050_b8-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180107184050_b9-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"4276s","DOI":"10.1158\/1078-0432.CCR-040010","article-title":"Pemetrexed (ALIMTA), a novel multitargeted anti-neoplastic agent","volume":"10","author":"Adjei","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180107184050_b10-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1053\/j.seminoncol.2005.02.010","article-title":"New agents in the management of advanced mesothelioma","volume":"32","author":"Vogelzang","year":"2005","journal-title":"Semin Oncol"},{"key":"key20180107184050_b11-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20180107184050_b12-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.lungcan.2007.02.004","article-title":"Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results","volume":"57","author":"Rea","year":"2007","journal-title":"Lung Cancer"},{"key":"key20180107184050_b13-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jtcvs.2007.10.054","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant mesothelioma: results in 663 patients","volume":"135","author":"Flores","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key20180107184050_b14-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jnci\/90.12.889","article-title":"Photodynamic therapy","volume":"90","author":"Dougherty","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"key20180107184050_b15-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/104454702753474931","article-title":"An update on photodynamic therapy applications","volume":"20","author":"Dougherty","year":"2002","journal-title":"J Clin Laser Med Surg"},{"key":"key20180107184050_b16-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1378\/chest.102.5.1319","article-title":"Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection","volume":"102","author":"Edell","year":"1992","journal-title":"Chest"},{"key":"key20180107184050_b17-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/lsm.20346","article-title":"Basic and clinical research on photodynamic therapy at Tokyo Medical University Hospital","volume":"38","author":"Kato","year":"2006","journal-title":"Lasers Surg Med"},{"issue":"Suppl 3","key":"key20180107184050_b18-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1378\/chest.07-1377","article-title":"Bronchial intraepithelial neoplasia\/early central airways lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)","volume":"132","author":"Kennedy","year":"2007","journal-title":"Chest"},{"key":"key20180107184050_b19-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/lsm.10113","article-title":"Experimental photodynamic therapy for malignant pleural mesothelioma with pegylated mTHPC","volume":"32","author":"Krueger","year":"2003","journal-title":"Laser Surg Med"},{"key":"key20180107184050_b20-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0003-4975(02)04474-0","article-title":"A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma","volume":"75","author":"Friedberg","year":"2003","journal-title":"Ann Thorac Surg"},{"issue":"Suppl 1","key":"key20180107184050_b21-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.lungcan.2005.03.024","article-title":"Photodynamic therapy as an adjunct to surgery for malignant pleural mesothelioma","volume":"49","author":"Ris","year":"2005","journal-title":"Lung Cancer"},{"key":"key20180107184050_b22-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/BF02303746","article-title":"Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma","volume":"4","author":"Pass","year":"1997","journal-title":"Ann Surg Oncol"},{"key":"key20180107184050_b23-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1158\/1078-0432.CCR-09-2520","article-title":"Outcome of photodynamic therapy using NPe6 for bronchogenic carcinomas in central airways >1.0 cm in diameter","volume":"16","author":"Usuda","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key20180107184050_b24-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1349-7006.2009.01358.x","article-title":"Significance of thymidylate synthase for resistance to pemetrexed in lung cancer","volume":"101","author":"Ozasa","year":"2010","journal-title":"Cancer Sci"},{"key":"key20180107184050_b25-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.lungcan.2009.04.008","article-title":"COX-2 specific inhibitors enhance the cytotoxic effects of pemetrexed in mesothelioma cell lines","volume":"67","author":"O\u2019Kane","year":"2010","journal-title":"Lung Cancer"},{"key":"key20180107184050_b26-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1074\/jbc.M205219200","article-title":"Domain-dependent photodamage to Bcl-2. A membrane anchorage region is needed to form the target of phthalocyanine photosensitization","volume":"278","author":"Usuda","year":"2003","journal-title":"J Biol Chem"},{"key":"key20180107184050_b27-ijo-46-02-0741","first-page":"689","article-title":"Tailor-made approach to photodynamic therapy in the treatment of cancer based on Bcl-2 photodamage","volume":"33","author":"Usuda","year":"2008","journal-title":"Int J Oncol"},{"key":"key20180107184050_b28-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0169-5002(03)00242-3","article-title":"Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorine e6 and diode laser for early superficial squamous cell carcinoma of the lung","volume":"42","author":"Kato","year":"2003","journal-title":"Lung Cancer"},{"key":"key20180107184050_b29-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.lungcan.2009.04.002","article-title":"Breast cancer resistant protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer","volume":"67","author":"Usuda","year":"2010","journal-title":"Lung Cancer"},{"key":"key20180107184050_b30-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/excr.2000.5108","article-title":"Photodynamic therapy-induced death of MCF-7 human breast cancer cells: a role for caspase-3 in the late steps of apoptosis but not for the critical lethal event","volume":"263","author":"Xue","year":"2001","journal-title":"Exp Cell Res"},{"key":"key20180107184050_b31-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/sj.bjc.6605642","article-title":"Guidelines for the welfare and use of animals in cancer research","volume":"102","author":"Workman","year":"2010","journal-title":"Br J Cancer"},{"key":"key20180107184050_b32-ijo-46-02-0741","first-page":"397","article-title":"High expression of GADD-45\u03b1 and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6","volume":"32","author":"Ohtani","year":"2008","journal-title":"Int J Oncol"},{"key":"key20180107184050_b33-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00280-010-1503-x","article-title":"The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice","volume":"68","author":"Van","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107184050_b34-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1309\/TWCQV536WWRNEU51","article-title":"Prognostic role of osteopontin expression in malignant pleural mesothelioma","volume":"130","author":"Cappia","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"key20180107184050_b35-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1200\/JCO.2009.25.9275","article-title":"Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with pemetrexed-based chemotherapy","volume":"28","author":"Righi","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20180107184050_b36-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/lsm.21115","article-title":"Leukocyte-endothelial cell interaction is necessary for photodynamic therapy induced vascular permeabilization","volume":"43","author":"Debefve","year":"2011","journal-title":"Lasers Surg Med"},{"key":"key20180107184050_b37-ijo-46-02-0741","first-page":"8126","article-title":"Photodynamic therapy: a means to enhanced drug delivery to tumors","volume":"63","author":"Snyder","year":"2003","journal-title":"Cancer Res"},{"key":"key20180107184050_b38-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/ejcts\/ezr294","article-title":"Photodynamic drug delivery enhancement in tumors does not depend on leukocyte-endothelial interaction in a human mesothelioma xenograft model","volume":"42","author":"Wang","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"key20180107184050_b39-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/bjc.1998.231","article-title":"Reduction of tumor oxygenation during and after photodynamic therapy in vivo: effects of fluence rate","volume":"77","author":"Sitnik","year":"1998","journal-title":"Br J Cancer"},{"key":"key20180107184050_b40-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1039\/b108586g","article-title":"The role of apoptosis in response to photodynamic therapy: what, where, why, and how","volume":"1","author":"Oleinick","year":"2002","journal-title":"Photochem photobiol Sci"},{"key":"key20180107184050_b41-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4161\/cbt.4.2.1440","article-title":"ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapy","volume":"4","author":"Robey","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"key20180107184050_b42-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1158\/1078-0432.CCR-08-3054","article-title":"Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo","volume":"15","author":"Anand","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180107184050_b43-ijo-46-02-0741","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/sj.bjc.6603273","article-title":"Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells","volume":"95","author":"Sinha","year":"2006","journal-title":"Br J Cancer"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2014.2746\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T18:44:35Z","timestamp":1515350675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2014.2746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,10]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,11,10]]},"published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.3892\/ijo.2014.2746"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2014.2746","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,10]]}}}